Ebele M Umeukeje1, Joseph R Merighi2, Teri Browne3, Jacquelyn N Victoroff4, Kausik Umanath5, Julia B Lewis1, T Alp Ikizler1, Kenneth A Wallston6, Kerri Cavanaugh7. 1. Division of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Kidney Disease, Nashville, Tennessee. 2. School of Social Work, University of Minnesota, Saint Paul, Minnesota. 3. College of Social Work, University of South Carolina, Columbia, South Carolina. 4. School of Medicine, University of Washington, Seattle, Washington. 5. Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan. 6. Vanderbilt University School of Nursing, Nashville, Tennessee. 7. Division of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Kidney Disease, Nashville, Tennessee. Electronic address: kerri.cavanaugh@vanderbilt.edu.
Abstract
OBJECTIVE: Hyperphosphatemia is common in end-stage renal disease and associates with mortality. Phosphate binders reduce serum phosphorus levels; however, adherence is often poor. This pilot study aims to assess patients' self-motivation to adhere to phosphate binders, its association with phosphorus control, and potential differences by race. DESIGN AND METHODS: Cross sectional design. Subjects were enrolled from one academic medical center dialysis practice from July to November 2012. Self-motivation to adhere to phosphate binders was assessed with the autonomous regulation (AR) scale (range: 1-7) and self-reported medication adherence with the Morisky Medication Adherence Scale. Linear regression models adjusting for age, sex, health literacy, and medication adherence were applied to determine associations with serum phosphorus level, including any evidence of interaction by race. RESULTS: Among 100 participants, mean age was 51 years (±15 years), 53% were male, 72% were non-white, 89% received hemodialysis, and mean serum phosphorus level was 5.7 ± 1.6 mg/dL. More than half (57%) reported the maximum AR score (7). Higher AR scores were noted in those reporting better health overall (P = .001) and those with higher health literacy (P = .01). AR score correlated with better medication adherence (r = 0.22; P = .02), and medication adherence was negatively associated with serum phosphorus (r = -0.40; P < .001). In subgroup analysis among non-whites, higher AR scores correlated with lower serum phosphorus (high vs lower AR score: 5.55 [1.5] vs 6.96 [2.2]; P = .01). Associations between AR score (β 95% confidence interval: -0.37 [-0.73 to -0.01]; P = .04), medication adherence (β 95% confidence interval: -0.25 [-0.42 to -0.07]; P = .01), and serum phosphorus persisted in adjusted analyses. CONCLUSIONS: Self-motivation was associated with phosphate binder adherence and phosphorus control, and this differed by race. Additional research is needed to determine if personalized, culturally sensitive strategies to understand and overcome motivational barriers may optimize mineral bone health in end-stage renal disease. Published by Elsevier Inc.
OBJECTIVE:Hyperphosphatemia is common in end-stage renal disease and associates with mortality. Phosphate binders reduce serum phosphorus levels; however, adherence is often poor. This pilot study aims to assess patients' self-motivation to adhere to phosphate binders, its association with phosphorus control, and potential differences by race. DESIGN AND METHODS: Cross sectional design. Subjects were enrolled from one academic medical center dialysis practice from July to November 2012. Self-motivation to adhere to phosphate binders was assessed with the autonomous regulation (AR) scale (range: 1-7) and self-reported medication adherence with the Morisky Medication Adherence Scale. Linear regression models adjusting for age, sex, health literacy, and medication adherence were applied to determine associations with serum phosphorus level, including any evidence of interaction by race. RESULTS: Among 100 participants, mean age was 51 years (±15 years), 53% were male, 72% were non-white, 89% received hemodialysis, and mean serum phosphorus level was 5.7 ± 1.6 mg/dL. More than half (57%) reported the maximum AR score (7). Higher AR scores were noted in those reporting better health overall (P = .001) and those with higher health literacy (P = .01). AR score correlated with better medication adherence (r = 0.22; P = .02), and medication adherence was negatively associated with serum phosphorus (r = -0.40; P < .001). In subgroup analysis among non-whites, higher AR scores correlated with lower serum phosphorus (high vs lower AR score: 5.55 [1.5] vs 6.96 [2.2]; P = .01). Associations between AR score (β 95% confidence interval: -0.37 [-0.73 to -0.01]; P = .04), medication adherence (β 95% confidence interval: -0.25 [-0.42 to -0.07]; P = .01), and serum phosphorus persisted in adjusted analyses. CONCLUSIONS: Self-motivation was associated with phosphate binder adherence and phosphorus control, and this differed by race. Additional research is needed to determine if personalized, culturally sensitive strategies to understand and overcome motivational barriers may optimize mineral bone health in end-stage renal disease. Published by Elsevier Inc.
Authors: Chandra Y Osborn; Kerri Cavanaugh; Kenneth A Wallston; Sunil Kripalani; Tom A Elasy; Russell L Rothman; Richard O White Journal: J Health Commun Date: 2011
Authors: Julie A Wright Nunes; Kenneth A Wallston; Svetlana K Eden; Ayumi K Shintani; T Alp Ikizler; Kerri L Cavanaugh Journal: Kidney Int Date: 2011-08-10 Impact factor: 10.612
Authors: Chantal S Levesque; Geoffrey C Williams; Diane Elliot; Michael A Pickering; Bradley Bodenhamer; Phillip J Finley Journal: Health Educ Res Date: 2006-11-30
Authors: Karen Wells; Manel Pladevall; Edward L Peterson; Janis Campbell; Mingqun Wang; David E Lanfear; L Keoki Williams Journal: Am J Respir Crit Care Med Date: 2008-10-10 Impact factor: 21.405
Authors: Ebele M Umeukeje; Joseph R Merighi; Teri Browne; Marcus Wild; Hafez Alsmaan; Kausik Umanath; Julia B Lewis; Kenneth A Wallston; Kerri L Cavanaugh Journal: J Behav Med Date: 2016-05-11
Authors: Marcus G Wild; Kenneth A Wallston; Jamie A Green; Lauren B Beach; Ebele Umeukeje; Julie A Wright Nunes; T Alp Ikizler; Julia Steed; Kerri L Cavanaugh Journal: Kidney Int Date: 2017-05-18 Impact factor: 10.612
Authors: Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie Journal: BMC Nephrol Date: 2019-10-17 Impact factor: 2.388
Authors: Marco D Boonstra; Sijmen A Reijneveld; Elisabeth M Foitzik; Ralf Westerhuis; Gerjan Navis; Andrea F de Winter Journal: Nephrol Dial Transplant Date: 2020-12-22 Impact factor: 5.992
Authors: Latrice C Pichon; Kristen R Rossi; Siri A Ogg; Lisa J Krull; Dorcas Young Griffin Journal: Int J Environ Res Public Health Date: 2015-06-19 Impact factor: 3.390